{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T13:36:05Z","timestamp":1773754565467,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,17]]},"DOI":"10.7759\/cureus.105367","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T11:40:31Z","timestamp":1773747631000},"source":"Crossref","is-referenced-by-count":0,"title":["Inhibitor-Free Variant of the Cheung Regimen: Successful Adjunctive Therapy in Long-Standing Hypochondriasis With Prominent Somatic Features"],"prefix":"10.7759","author":[{"given":"Ngo","family":"Cheung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.112.115402","article-title":"Hypochondriasis and health anxiety: conceptual challenges","volume":"202","author":"Starcevic V","year":"2013","unstructured":"Starcevic V. Hypochondriasis and health anxiety: conceptual challenges. Br J Psychiatry. 2013, 202:7-8. 10.1192\/bjp.bp.112.115402","journal-title":"Br J Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","article-title":"","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. American Psychiatric Association Publishing, Washington, DC; 2013. 10.1176\/appi.books.9780890425596https:\/\/doi.org\/10.1176\/appi.books.9780890425596."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbtep.2009.06.005","article-title":"Cognitive behavioral therapy versus paroxetine in the treatment of hypochondriasis: an 18-month naturalistic follow-up","volume":"40","author":"Greeven A","year":"2009","unstructured":"Greeven A, van Balkom AJ, van der Leeden R, Merkelbach JW, van den Heuvel OA, Spinhoven P. Cognitive behavioral therapy versus paroxetine in the treatment of hypochondriasis: an 18-month naturalistic follow-up. J Behav Ther Exp Psychiatry. 2009, 40:487-96. 10.1016\/j.jbtep.2009.06.005","journal-title":"J Behav Ther Exp Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s40501-015-0051-8","article-title":"Glutamatergic agents for OCD and related disorders","volume":"2","author":"Pittenger C","year":"2015","unstructured":"Pittenger C. Glutamatergic agents for OCD and related disorders. Curr Treat Options Psychiatry. 2015, 2:271-83. 10.1007\/s40501-015-0051-8","journal-title":"Curr Treat Options Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2013.150","article-title":"Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept","volume":"38","author":"Rodriguez CI","year":"2013","unstructured":"Rodriguez CI, Kegeles LS, Levinson A, et al.. Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept. Neuropsychopharmacology. 2013, 38:2475-83. 10.1038\/npp.2013.150","journal-title":"Neuropsychopharmacology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852919001470","article-title":"Dextromethorphan\/bupropion: a novel oral NMDA (N-methyl-d-aspartate) receptor antagonist with multimodal activity","volume":"24","author":"Stahl SM","year":"2019","unstructured":"Stahl SM. Dextromethorphan\/bupropion: a novel oral NMDA (N-methyl-d-aspartate) receptor antagonist with multimodal activity. CNS Spectr. 2019, 24:461-6. 10.1017\/S1092852919001470","journal-title":"CNS Spectr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.21080800","article-title":"Effect of AXS-05 (dextromethorphan-bupropion) in major depressive disorder: a randomized double-blind controlled trial","volume":"179","author":"Tabuteau H","year":"2022","unstructured":"Tabuteau H, Jones A, Anderson A, Jacobson M, Iosifescu DV. Effect of AXS-05 (dextromethorphan-bupropion) in major depressive disorder: a randomized double-blind controlled trial. Am J Psychiatry. 2022, 179:490-9. 10.1176\/appi.ajp.21080800","journal-title":"Am J Psychiatry"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Cheung N. DXM, CYP2D6-inhibiting antidepressants, piracetam, and glutamine: proposing a ketamine-class antidepressant regimen with existing drugs. (2025). Accessed: 02 March, 2026: https:\/\/www.preprints.org\/manuscript\/202511.1815.","DOI":"10.20944\/preprints202511.1815.v1"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.18005844","article-title":"Remission of obsessive ruminations using a low-intensity glutamatergic stack: a retrospective case observation of dextromethorphan and piracetam with minimal CYP2D6 inhibition","author":"Cheung N","year":"2025","unstructured":"Cheung N. Remission of obsessive ruminations using a low-intensity glutamatergic stack: a retrospective case observation of dextromethorphan and piracetam with minimal CYP2D6 inhibition. Zenodo. 2025, 10.5281\/zenodo.18005844","journal-title":"Zenodo"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke K","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001, 16:606-13. 10.1046\/j.1525-1497.2001.016009606.x","journal-title":"J Gen Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer RL","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JB, L\u00f6we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006, 166:1092-7. 10.1001\/archinte.166.10.1092","journal-title":"Arch Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1021\/jm901905j","article-title":"Piracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors","volume":"53","author":"Ahmed AH","year":"2010","unstructured":"Ahmed AH, Oswald RE. Piracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors. J Med Chem. 2010, 53:2197-203. 10.1021\/jm901905j","journal-title":"J Med Chem"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1992.tb11329.x","article-title":"Nootropic drugs positively modulate alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-sensitive glutamate receptors in neuronal cultures","volume":"58","author":"Copani A","year":"1992","unstructured":"Copani A, Genazzani AA, Aleppo G, Casabona G, Canonico PL, Scapagnini U, Nicoletti F. Nootropic drugs positively modulate alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-sensitive glutamate receptors in neuronal cultures. J Neurochem. 1992, 58:1199-204. 10.1111\/j.1471-4159.1992.tb11329.x","journal-title":"J Neurochem"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2015.03.024","article-title":"Involvement of AMPA receptors in the antidepressant-like effects of dextromethorphan in mice","volume":"295","author":"Nguyen L","year":"2015","unstructured":"Nguyen L, Matsumoto RR. Involvement of AMPA receptors in the antidepressant-like effects of dextromethorphan in mice. Behav Brain Res. 2015, 295:26-34. 10.1016\/j.bbr.2015.03.024","journal-title":"Behav Brain Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1985.235","article-title":"Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquin hydroxylation","volume":"38","author":"Schmid B","year":"1985","unstructured":"Schmid B, Bircher J, Preisig R, K\u00fcpfer A. Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquin hydroxylation. Clin Pharmacol Ther. 1985, 38:618-24. 10.1038\/clpt.1985.235","journal-title":"Clin Pharmacol Ther"},{"key":"ref16","doi-asserted-by":"crossref","DOI":"10.1016\/S0026-895X(25)09118-7","article-title":"Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4","volume":"36","author":"Kronbach T","year":"1989","unstructured":"Kronbach T, Mathys D, Umeno M, Gonzalez FJ, Meyer UA. Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4. Mol Pharmacol. 1989, 36:89-96.","journal-title":"Mol Pharmacol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1029073","article-title":"Physiologically based pharmacokinetic (PBPK) modeling of the role of CYP2D6 polymorphism for metabolic phenotyping with dextromethorphan","volume":"13","author":"Grzegorzewski J","year":"2022","unstructured":"Grzegorzewski J, Brandhorst J, K\u00f6nig M. Physiologically based pharmacokinetic (PBPK) modeling of the role of CYP2D6 polymorphism for metabolic phenotyping with dextromethorphan. Front Pharmacol. 2022, 13:1029073. 10.3389\/fphar.2022.1029073","journal-title":"Front Pharmacol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041867","article-title":"The serotonin syndrome","volume":"352","author":"Boyer EW","year":"2005","unstructured":"Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005, 352:1112-20. 10.1056\/NEJMra041867","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/464601-inhibitor-free-variant-of-the-cheung-regimen-successful-adjunctive-therapy-in-long-standing-hypochondriasis-with-prominent-somatic-features","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T11:40:32Z","timestamp":1773747632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/464601-inhibitor-free-variant-of-the-cheung-regimen-successful-adjunctive-therapy-in-long-standing-hypochondriasis-with-prominent-somatic-features"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.105367","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,17]]}}}